Description
Retatrutide Overview
Retatrutide is a triple agonist peptide commonly utilized in laboratory research involving GLP-1, GIP, and glucagon receptor signaling pathways. This compound is frequently studied in metabolic regulation, energy balance, peptide-receptor interactions, and endocrine signaling research. It is supplied as a lyophilized powder and is intended strictly for laboratory and analytical research applications.
Product Specifications
- Compound: Retatrutide
- Quantity: 10 vial kit
- Appearance: Lyophilized Powder
- Grade: Research Grade
- Packaging: Sealed Sterile Vial
- Intended Use: Laboratory Research Only
Batch Documentation
- COA Type: Manufacturer Certificate of Analysis
- Batch Number: RET-26031501
- Manufacturing Date: Mar. 15, 2026
- Retest Date: Mar. 14, 2028
View the manufacturer Certificate of Analysis (COA) in the product image gallery above.
Research Applications
Retatrutide is commonly utilized in laboratory studies involving incretin receptor signaling, glucagon receptor activity, metabolic regulation, peptide-receptor interactions, energy expenditure pathways, and endocrine signaling mechanisms. This compound is intended exclusively for scientific and analytical use.
Research Use Only
This product is not intended for human consumption, medical use, therapeutic application, or diagnostic procedures. By purchasing this product, the customer acknowledges they are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.
Reviews
There are no reviews yet.